Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$225,012,862
-$8,200,622 QoQ
Shares Held
1,614,500
-15.0% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 76.64744502942087.ToString("F0")%
None 23.352554970579124.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NATIONAL BANK OF CANADA /FI/ holds $2,581,293,363 across 17 Drug Manufacturers - General names. GILD ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
620,178 | $570,421,117 | |
| 2 | JNJ |
Johnson & Johnson
|
1,731,044 | $423,136,394 | |
| 3 | AZN |
Astrazeneca PLC
|
2,137,511 | $421,559,918 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,961,390 | $235,935,600 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
1,614,500 | $225,012,862 | |
| 6 | ABBV |
AbbVie Inc.
|
927,136 | $201,642,805 | |
| 7 | AMGN |
Amgen Inc
|
420,993 | $148,126,385 | |
| 8 | PFE |
Pfizer Inc
|
5,136,267 | $144,226,376 |
All Filings in GILD
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $225,012,862 | 1,614,500 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $233,213,484 | 1,900,061 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $161,138,034 | 1,451,694 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $142,746,452 | 1,287,512 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $182,221,310 | 1,626,250 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $140,244,075 | 1,518,286 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $139,932,229 | 1,669,039 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $114,690,601 | 1,671,631 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $59,433,216 | 811,375 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $94,444,129 | 1,165,833 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $78,076,086 | 1,041,848 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $77,461,205 | 1,005,076 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $54,370,404 | 655,302 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $36,781,400 | 428,438 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $10,691,616 | 173,312 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $35,729,207 | 578,049 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $11,235,930 | 188,998 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $37,120,990 | 511,238 | Shares | Defined | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||